About the 3D Bioprinting for Drug Discovery Session
3D Bioprinting for Drug Discovery, The landscape of drug discovery is undergoing a transformative shift with the integration of 3D bioprinting technology. This ground-breaking approach allows researchers to fabricate three-dimensional tissue models that closely mimic the complexity of human organs. In drug testing, these 3D bioprinted tissues offer a more accurate representation of in-vivo conditions compared to traditional two-dimensional cell cultures. This precision enables a more reliable assessment of a drug's efficacy, toxicity, and potential side effects. By replicating the microenvironments of specific organs, 3D Bioprinting for Drug Discovery facilitates a more targeted and realistic exploration of how drugs interact with human tissues. This advancement holds immense promise for accelerating the drug discovery process, reducing the reliance on animal testing, and ultimately bringing safer and more effective medications to market.
Topics Covered in 3D Bioprinting for Drug Discovery
Bioink Formulation and Optimization
Organ-on-a-Chip Models
High-Throughput Drug Screening Platforms
Tumor Microenvironment Modeling
Vascularized Tissue Constructs
Personalized Medicine Applications
Related Scientific Sessions at Materials 2027
Why Attend the 3D Bioprinting for Drug Discovery Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original 3D Bioprinting for Drug Discovery work, reviewed by the scientific committee.
Network Globally
Meet materials researchers, engineers, and academics from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping 3D Bioprinting for Drug Discovery research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join Materials 2027 for the 3D Bioprinting for Drug Discovery track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
3D Bioprinting for Drug Discovery Conference 2027 — FAQs
What is the 3D Bioprinting for Drug Discovery track at Materials 2027?
The 3D Bioprinting for Drug Discovery track is a dedicated stream within Materials 2027 covering the latest research, methods, and applications in 3D Bioprinting for Drug Discovery. It brings together researchers, engineers, and academics for oral presentations, posters, and discussion.
Who should attend the 3D Bioprinting for Drug Discovery sessions?
Materials researchers, engineers, educators, doctoral students, and R&D leaders with an interest in 3D Bioprinting for Drug Discovery are all welcome — whether presenting or attending.
Can I present my research in the 3D Bioprinting for Drug Discovery track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for 3D Bioprinting for Drug Discovery sessions?
Yes. Materials 2027 is a hybrid conference — attend the 3D Bioprinting for Drug Discovery track in person in Singapore or join live online, with on-demand access afterward.
Join the Materials 2027 delegation
Singapore · March 18–20, 2027· Hybrid · in-person & virtual
Attend without presenting.